News & Investors
News
Lumicell Supports Stand Up To Cancer Dream Team for Early Detection of Gastric Cancer with Investigational Device and New Drug
Global Team Will Launch Gastric Cancer Prevention Clinical Trial. CAUTION – Investigational device and new drug. Limited by Federal (or United States) law to investigational use.
- Los Angeles
- January 8, 2026
Lumicell Phase 1 Results Presented at SSO 2015 Annual Cancer Symposium
Phase 1 Results Also Presented at AACR 2015 Annual Meeting Wellesley, Mass., May 8, 2015 – Lumicell, a leader in the field of image-guided cancer surgery, announced that Phase 1 trial
Lumicell Awarded SBIR Phase IIB Grant from National Science Foundation
Grant will support development of novel image-guided laser ablation system in collaboration with Massachusetts General Hospital, Brigham and Women’s Hospital and Duke University Medical Center Wellesley, Mass., May 14, 2014 –
Lumicell Awarded SBIR Grant from the National Cancer Institute
Grant will support development of new imaging agents in collaboration with MIT, MGH and Duke University Medical Center Wellesley, Mass., August 7, 2013 – Lumicell, a leader in
Lumicell Awarded with an Accelerator Loan from the Massachusetts Life Sciences Center
Wellesley, Mass., May 29, 2013 – Lumicell announced it was awarded a $1 million accelerator loan from the Massachusetts Life Sciences Center (MLSC), a quasi-public agency charged with implementing the state’s
Events
San Antonio Breast Cancer Symposium®,
December 10-14, 2024
Henry B. Gonzalez Convention Center
Investors
